On slide #13, it has been mentioned that "DMX-200 is the only therapy in phase 3 development". However, a quick search showed that FILSPARI® (sparsentan) is also in phase 3. From one website, my understanding is it is for IgA nephropathy; however, another website mentioned FSGS, too. Can anyone shed some light on this?
On slide #13, it has been mentioned that "DMX-200 is the only...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.3¢ |
Change
-0.008(2.21%) |
Mkt cap ! $182.7M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 33.0¢ | $231.7K | 699.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 415000 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 97000 | 2 |
View Market Depth
| Last trade - 11.32am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.0¢ |
Change
-0.008 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 33.0¢ | 34.0¢ | 33.0¢ | 369483 | ||
| Last updated 11.55am 24/05/2024 ? | |||||
| DXB (ASX) Chart |